Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Share-based Compensation (2019 - 2025)

Quantum Biopharma's Share-based Compensation history spans 7 years, with the latest figure at $808452.0 for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 1300.09% to $808452.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 907.24% increase, with the full-year FY2025 number at $2.9 million, up 1835.11% from a year prior.
  • Share-based Compensation hit $808452.0 in Q4 2025 for Quantum Biopharma, down from $996194.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for QNTM hit a ceiling of $3.2 million in Q1 2023 and a floor of $57743.0 in Q1 2024.
  • Historically, Share-based Compensation has averaged $806203.5 across 5 years, with a median of $208717.5 in 2023.
  • Biggest five-year swings in Share-based Compensation: surged 3755.82% in 2023 and later tumbled 98.2% in 2024.
  • Tracing QNTM's Share-based Compensation over 5 years: stood at $3.0 million in 2021, then crashed by 97.25% to $83161.0 in 2022, then skyrocketed by 51.71% to $126163.0 in 2023, then crashed by 54.23% to $57743.0 in 2024, then soared by 1300.09% to $808452.0 in 2025.
  • Business Quant data shows Share-based Compensation for QNTM at $808452.0 in Q4 2025, $996194.0 in Q3 2025, and $849584.0 in Q2 2025.